Switch to:
More From Other Websites
7:16 am The Medicines Co: FDA has accepted for priority review its NDA filing for Carbavance for the... Feb 21 2017
The Medicines Company Announces FDA Filing Acceptance of New Drug Application for Intravenous... Feb 21 2017
The Medicines Company to Announce Fourth-Quarter and Full-Year 2016 Financial Results on February... Feb 17 2017
Biotech Premarket Movers: Ardelyx, Acorda Therapeutics, Medicines Co. Feb 15 2017
Alnylam (ALNY) Q3 Loss Narrower than Expected, Revenues Rise Feb 09 2017
Amgen's LDL-Buster Boosts The Medicines Co., But Regeneron Slides Feb 03 2017
Amgen CEO: Will work with Trump to lower drug prices Feb 02 2017
The Medicines Company to Present Results from ORION-1 Phase 2 Study of Inclisiran at the American... Jan 25 2017
The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : January 23,... Jan 23 2017
ETFs with exposure to The Medicines Co. : January 20, 2017 Jan 20 2017
The Medicines Co LDL-Lowering Drug Positive in Phase II Jan 09 2017
The Medicines Company Announces Positive Top-Line Results from Day 180 Interim Analysis in Ongoing... Jan 08 2017
Could Sanofi Acquire BioMarin In Wake Of Amgen LDL Brouhaha? Jan 06 2017
[video]Amgen Shares Skyrocket on Surprise Patent Victory, Plus Jim Cramer's View Jan 06 2017
These 5 Biotech Stocks Could Be Big Takeover Targets in 2017 Jan 06 2017
The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : January 5, 2017 Jan 05 2017
The Medicines Company to Present at J. P. Morgan Healthcare Conference Jan 04 2017
The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : December 23,... Dec 23 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK